SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma

Pier Luigi Zinzani, Monia Marchetti, Atto Billio, Giovanni Barosi, Angelo Michele Carella, Mario Lazzarino, Maurizio Martelli, Alessandro Rambaldi, Luigi Rigacci, Corrado Tarella, Umberto Vitolo, Sante Tura

Research output: Contribution to journalArticle

Abstract

By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issued in 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmunotherapy in patients with Stage III-IV disease and/or high tumor burden. Maintenance rituximab was also recommended in responding patients. In patients relapsing after an interval longer than 12 months from frontline therapy, we recommended chemoimmunotherapy with non cross-resistant regimens followed by rituximab maintenance. High dose chemotherapy followed by hematopoietic stem cell transplant was recommended for young fit patients who achieve a response after salvage chemoimmunotherapy.

Original languageEnglish
Pages (from-to)185-192
Number of pages8
JournalAmerican Journal of Hematology
Volume88
Issue number3
DOIs
Publication statusPublished - Mar 2013

    Fingerprint

ASJC Scopus subject areas

  • Hematology

Cite this

Zinzani, P. L., Marchetti, M., Billio, A., Barosi, G., Carella, A. M., Lazzarino, M., Martelli, M., Rambaldi, A., Rigacci, L., Tarella, C., Vitolo, U., & Tura, S. (2013). SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma. American Journal of Hematology, 88(3), 185-192. https://doi.org/10.1002/ajh.23372